Cargando...
Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
OBJECTIVE: To investigate the effect of enriching mild cognitive impairment (MCI) clinical trials using combined markers of amyloid pathology and neurodegeneration. METHODS: We evaluate an implementation of the recent National Institute for Aging–Alzheimer's Association (NIA-AA) diagnostic crit...
Guardado en:
| Publicado en: | Neurology |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035986/ https://ncbi.nlm.nih.gov/pubmed/27558378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003126 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|